BridgeBio Pharma, Inc. (BBIO)

BridgeBio Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	392.59	414.62	393.95	356.08	363.77
Short-Term Investments	58.95	95.23	442.89	251.01	182.22
Cash & Cash Equivalents	451.54	509.85	836.84	607.09	545.99
Cash Growth	-11.44%	-39.07%	37.84%	11.19%	25.20%
Receivables	1.75	17.08	19.75	0	2.85
Other Current Assets	24.31	21.92	32.27	35.73	19.78
Total Current Assets	477.59	548.85	888.86	642.82	568.62
Property, Plant & Equipment	19.84	25.25	45.97	36.83	5.63
Long-Term Investments	0	0	0	0	31.14
Goodwill and Intangibles	26.32	28.71	44.93	0	0
Other Long-Term Assets	22.63	20.22	33.03	23.93	26.29
Total Long-Term Assets	68.79	74.18	123.93	60.76	63.06
Total Assets	546.38	623.04	1,013	703.59	631.68
Accounts Payable	10.66	11.56	11.88	8.95	8.85
Deferred Revenue	9.82	8.16	0	0	0
Current Debt	4.13	3.68	4.94	5.25	0
Other Current Liabilities	119.24	98.04	118.25	81.45	51.53
Total Current Liabilities	143.84	121.43	135.07	95.65	60.39
Long-Term Debt	1,736	1,720	1,721	490.53	91.79
Other Long-Term Liabilities	9.36	26.64	22.07	9.52	3.53
Total Long-Term Liabilities	1,745	1,747	1,743	500.05	95.32
Total Liabilities	1,889	1,868	1,878	595.7	155.7
Total Debt	1,740	1,724	1,726	495.79	91.79
Debt Growth	0.94%	-0.15%	248.17%	440.13%	68.40%
Retained Earnings	-2,560.5	-1,918.15	-1,436.97	-888.76	-440.03
Comprehensive Income	0.03	-0.33	-0.13	0.19	0.25
Shareholders' Equity	-1,354.26	-1,254.62	-870.41	57.91	408.45
Net Cash / Debt	-1,288.3	-1,213.71	-889.33	111.31	454.2
Net Cash / Debt Growth	-	-	-	-75.49%	19.03%
Net Cash Per Share	-7.91	-8.23	-6.16	0.94	4.32
Working Capital	333.75	427.43	753.79	547.18	508.24
Book Value Per Share	-8.32	-8.51	-6.03	0.49	3.89

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).